Grown Financial Statements From 2010 to 2024
| GRUSF Stock | USD 0.65 0.02 2.99% |
Check Grown Rogue financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Grown Rogue's main balance sheet or income statement drivers, such as , as well as many indicators such as . Grown financial statements analysis is a perfect complement when working with Grown Rogue Valuation or Volatility modules.
Grown |
Grown Rogue International OTC Stock Profit Margin Analysis
Grown Rogue's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Grown Rogue Profit Margin | 0.06 % |
Most of Grown Rogue's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grown Rogue International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Grown Rogue International has a Profit Margin of 0.0557%. This is 100.5% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 104.39% lower than that of the firm.
Grown Rogue International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grown Rogue's current stock value. Our valuation model uses many indicators to compare Grown Rogue value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grown Rogue competition to find correlations between indicators driving Grown Rogue's intrinsic value. More Info.Grown Rogue International is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Grown Rogue International is roughly 1.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Grown Rogue's earnings, one of the primary drivers of an investment's value.About Grown Rogue Financial Statements
Grown Rogue stakeholders use historical fundamental indicators, such as Grown Rogue's revenue or net income, to determine how well the company is positioned to perform in the future. Although Grown Rogue investors may analyze each financial statement separately, they are all interrelated. For example, changes in Grown Rogue's assets and liabilities are reflected in the revenues and expenses on Grown Rogue's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Grown Rogue International. Please read more on our technical analysis and fundamental analysis pages.
Grown Rogue International Inc., through its subsidiaries, engages in growing and selling cannabis products in the United States. Grown Rogue International Inc. is headquartered in Medford, Oregon. Grown Rogue operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Grown OTC Stock
Grown Rogue financial ratios help investors to determine whether Grown OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grown with respect to the benefits of owning Grown Rogue security.